After more than five years at the helm of embattled Biogen Inc., Michel Vounatsos is stepping down as CEO, the company announced Tuesday morning, and plans to implement "additional cost-reduction and productivity measures" to save about $1 billion.
Vounatsos will stay in the corner office until Biogen finds his replacement. The company has already begun the search, according to a statement.
WATCH ANYTIME FOR FREE
Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
Copyright Boston Business Journal